House Republicans unveiled a comprehensive 111-page healthcare plan, titled the “Lower Health Care Premiums for All Americans Act,” late Friday, ahead of an expected vote next week.
The legislation includes several measures focusing on market reforms and price transparency that are broadly popular within the Republican party but the political realities in the Senate mean it is unlikely to pass.
Central to the proposed plan are provisions designed to expand access and lower costs. The bill seeks to codify and expand association health plans (AHPs), allowing small businesses and self-employed individuals to band together to purchase coverage, thereby accessing greater bargaining power.
Republicans also plan to appropriate funding for cost-sharing reductions (CSRs) beginning in 2027, intended to lower out-of-pocket medical costs in the individual healthcare market.
GOP leadership aides project this specific provision could bring down the cost of premiums by 12%. However, this complicated funding mechanism for CSRs is estimated to potentially cause hundreds of thousands of people to lose insurance, while also decreasing the overall amount of subsidies available.
The plan further includes new transparency requirements aimed at Pharmacy Benefit Managers (PBMs), who act as intermediaries between pharmaceutical companies and insurers, negotiating drug prices and handling administrative tasks. These PBMs have faced bipartisan criticism in Congress for allegedly contributing to inflated health costs.
The most politically challenging omission from the legislation is the lack of an extension for the enhanced Obamacare subsidies, which are set to expire at the end of the year, threatening “drastically increased premium payments” for 22 million Americans. This issue has created fierce inter-party debate and internal division among Republicans. A majority of conservatives are against the extension, arguing that the subsidies are too costly and merely prop up a failing system.
In an effort to appease moderate Republicans who have vehemently pushed for action, House GOP leaders signaled they would allow an amendment vote on extending the subsidies next week. However, this amendment process is viewed as a concession intended to give moderates “political cover,” and it faces significant obstacles.
House Minority Leader Hakeem Jeffries (D-N.Y.) stated that Democrats would evaluate good faith proposals, but warned that the current Republican package is “likely to be a disaster” that would not enhance Americans’ healthcare. Any successful push to extend the subsidies would require near-unanimous Democratic support.
Republicans warn that if a subsidy extension amendment were adopted, it would act as a “poison pill” that would likely erode conservative backing for the larger healthcare bill, suggesting the overall plan has little chance of becoming law.